Form EFFECT NeuroBo Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 24, 2024 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CLINUVEL implements strategic reorganisation to refocus on U.S. markets
- Harju Elekter Group financial results, 1-6/2026
- InfiMotion Technology Makes Public Debut, Showcasing Full-Stack E‑Drive Capabilities at Wuxi Event
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
